Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 1 Upper panel: Partial volume corrected myocardial blood flow (ml/g/min) in biopsy regions in patients with reversible dysfunction (circles, n = 11) and irreversible dysfunction (squares, n = 12). Mean ± standard deviation is shown for each type of region. *p < 0.05 (two-way repeated measures analysis of variance, test for interaction, i.e., differences (control-dysfunctional myocardium) in the reversibly dysfunctional group versus differences in the irreversibly dysfunctional group). Ninety-five percent confidence intervals for the mean difference between dysfunctional and control regions: patients with reversible dysfunction: (–0.20; –0.05 ml/g/min). Patients with irreversible dysfunction: (–0.33; –0.14 ml/g/min). Lower panel: Relative FDG uptake (%) in biopsy regions in patients with reversible dysfunction (circles, n = 11) and irreversible dysfunction (squares, n = 12). Mean ± standard deviation is shown for each type of region. {dagger}p < 0.001. Ninety-five percent confidence intervals for the mean difference between dysfunctional and control regions: patients with reversible dysfunction: (–16; 10%). Patients with irreversible dysfunction: (–57; –27%). FDG = 18F-fluoro-2-deoxyglucose.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement